Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "celgene corporation headquarters"

Celgene Corporation Announces 2015 and Long-Term Financial Outlook and Preliminary 2014 Results
TeleTrader.com

Celgene Reaffirms

--- U.S. and EU Decisions on REVLIMID(R) NDMM Expected in Q1 Celgene Corporation (CELG) reported operating results for the fourth quarter and full year of 2014. For the fourth quarter of 2014, net product sales were $2,055 million compared to ... Earnings Whispers, 11 hours ago
[x]  

Celgene Corporation Earns CEO Cancer Gold Standard Accreditation

(BUSINESS WIRE) -- Celgene Corporation, a global biopharmaceutical company headquartered in Summit, New Jersey, has earned the prestigious global CEO Cancer Gold Standard(TM) accreditation. This accreditation recognizes the ...
 PredictWallStreet1 month ago Celgene Earns CEO Cancer Gold Standard Accreditation  BioSpace1 month ago
[x]  

Celgene Receives Positive CHMP Opinion for ABRAXANE® for First-Line Treatment of Patients with Non-Small Cell Lung Cancer

BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (CELG), today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...
 Yahoo! UK and Ireland6 days ago CELGENE : Receives Positive CHMP Opinion for ABRAXANE® for First-Line Treatment of Patients with Non-Small Cell Lung Cancer  4 Traders6 days ago Oral OTEZLA® (apremilast) Approved by the European Commission for the Treatment of both Patients with Psoriasis and Psoriatic Arthritis  Wall Street Business Network1 week ago Celgene International S??rl Release: Oral OTEZLA?? (Apremilast) Approved By The European Commission For The Treatment Of Both Patients With Psoriasis And Psoriatic Arthritis  BioSpace1 week ago
[x]  

Combination of ISTODAX® (romidepsin) and Standard CHOP Demonstrates a Complete Response in 51% of Patients with Peripheral T-Cell Lymphoma

SAN FRANCISCO--(BUSINESS WIRE)--Dec. 9, 2014-- Celgene Corporation In the phase Ib and phase II portions of this study, presented by Jehan Dupuis, M.D. (from the Lymphoma Study Association or LYSA), a total of 37 patients were treated with ...
 BusinessWeek1 month ago Celgene Release: Results From Phase 3 Study Of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence In Patients With Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented At American Society of Hematology  BioSpace1 month ago Celgene : Data Presented on REVLIMID® (lenalidomide) Compared with Investigators' Choice in Relapsed/Refractory Diffuse Large B-Cell Lymphoma  4 Traders1 month ago Combination of ISTODAX (romidepsin) and Standard CHOP Demonstrates a Complete Response in 51% of Patients with Peripheral T-Cell Lymphoma  Pharmacy Choice1 month ago
[x]  
Yahoo! Finance

New Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition

[December 08, 2014] Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma Inc. (NASDAQ:XLRN) today announced preliminary data from ongoing phase 2 clinical trials in patients with lower risk myelodysplastic syndromes ...
 Green Technology1 month ago Celgene Release: New Data In Myelodysplastic Syndromes Presented At The 56th American Society of Hematology Annual Meeting And Exposition  BioSpace1 month ago Celgene Release: New Data From Luspatercept Phase 2 Clinical Trial In Beta-Thalassemia Presented at the 56th American Society of Hematology Annual Meeting and Exposition  BioSpace1 month ago New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition  BioMedReports1 month ago
[x]  
Proactive Investors USA

Monday Deal Review - January 12 2015

PharmaCan Capital Corp. (formerly Searchtech Ventures Inc.) (the Corporation) (TSX VENTURE:MJN) announced that subject to the completion of filings with the TSX Venture Exchange (the Exchange) it has closed its qualifying transaction (the Qualifying ...
 MENAFN2 weeks ago Monday Deal Review - January 26, 2015  Proactive Investors USA2 days ago Monday Deal Review - January 12, 2015  Proactive Investors USA2 weeks ago
Pharmaceutical Manufacturing Magazine

Prolong Pharmaceuticals Moves Into New Headquarters

Prolong Pharmaceuticals LLC announced the expansion of its South Plainfield, N.J., manufacturing facility. A new long-term lease on the space adjoining its current facility is adding 24,000 square feet to the existing 24,000 square feet. In ...
 Pharmaceutical Manufacturing Magazine1 week ago

Chef Michael Ferraro, the Pancreatic Cancer Action Network and Meals to Heal Team up with Celgene to Address Nutritional Needs and Challenges Faced by Pancreatic Cancer Patients and Caregivers

As the holidays approach, most of us are conjuring up images of a perfectly roasted turkey with all the fixings, followed by a luscious pumpkin pie and perhaps an overfull stomach. People with pancreatic cancer are facing a very different dilemma: ...
 Stock Nod2 months ago

Father of PEGylation to Receive Dr. Sol J. Barer Award at Gateway Gala, BioNJ's 22st Annual Dinner Meeting, Networking Event and Innovation...

Father of PEGylation to Receive Dr. Sol J. Barer Award at Gateway Gala, BioNJ's 22st Annual Dinner Meeting, Networking Event and Innovation Celebration By a News Reporter-Staff News Editor at Biotech Week Abraham Abuchowski, Ph.D., considered ...
 Pharmacy Choice1 day ago
[x]  

Halozyme Therapeutics, Inc. (HALO) Appoints Jean-Pierre Bizzari, M.D. To Board Of Directors

SAN DIEGO, Jan. 21, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Jean-Pierre Bizzari, M.D. to its Board of Directors. Dr. Bizzari brings extensive experience in oncology drug development. "I ...
 FierceBiotech6 days ago Halozyme Therapeutics, Inc. Appoints To Board Of Directors  BioSpace1 week ago Halozyme Therapeutics : Appoints Jean-Pierre Bizzari, M.D. To Board Of Directors  4 Traders1 week ago Halozyme Appoints Jean-Pierre Bizzari, MD to Board Of Directors  DermWire1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less